![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.00 | -0.06% | 1,594.00 | 1,593.50 | 1,594.50 | 1,612.50 | 1,591.00 | 1,600.50 | 1,320,867 | 14:40:43 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.31 | 65.6B |
Date | Subject | Author | Discuss |
---|---|---|---|
26/10/2017 16:11 | They didn't give her much chance to say anything. Obviously she can't make strict commitments on the dividend beyond what they've already stated. And of course GSK will be looking at options re: Pfizer sale as will all its peers. But will GSK be buying $15bn of consumer healthcare from Pfizer? - I seriously doubt it. They might pick out one or two specific brands with synergies, but that's it. Some of the analysts weren't interested in doing anything but trying to catch her out on the dividend. They played rough with the new CEO, now analyst reports flying around saying that GSK dividend is under threat. | ![]() romeike | |
26/10/2017 16:09 | Brave. Unless you have funds for settlement. | ![]() essentialinvestor | |
26/10/2017 16:07 | I'm on a T20, has to bounce, this is silly | ![]() che7win | |
26/10/2017 16:05 | Fall is overdone imho, 19p dividend to holders on 9th Nov | ![]() che7win | |
26/10/2017 16:04 | Wow...so the reaction to our CEO comments yesterday when there were "some" positive developments going forward has knocked £7 billion off the market cap..... she must be feeling great! Certainly her words may have been better expressed over potential acquisitions, and now I guess some big players will be running their numbers over GSK's own consumer business...the tables may have turned. Maybe some over reaction but her comments have caused some concern how she intends to proceed..she really needed to express some caution, and be a bit more tight lipped. As they say we are where we are, so I guess the market will calm down and our CEO will highlight the current strength in its main sectors of operation, and perhaps play down the acquistion possibilities, as just possibilities. Finally, I think it is incumbant on her (especially now) to gain the confidence of the key Institutions which she will need to win over before embarking on any acquisitions. | ![]() cyberian | |
26/10/2017 16:01 | Discussed from 11.36 at | ![]() zho | |
26/10/2017 15:59 | Bought some 13.77 | ![]() che7win | |
26/10/2017 15:58 | Wow overeaction. | ![]() montyhedge | |
26/10/2017 15:52 | It's not ex div next Thursday, two weeks time | ![]() che7win | |
26/10/2017 15:50 | Sorry got mixed up with another stock.. 5.8% Got it from Will try and grab some around 1350p ish | ![]() ny boy | |
26/10/2017 15:36 | @1374, MT I'm guessing you are buying in larger amounts than me!. | ![]() essentialinvestor | |
26/10/2017 15:36 | Where are you getting this 7.7% figure from? Last dividend for full year was 80p, which makes the yield about 5.8% if bought at the current price of 1,375p | george4064 | |
26/10/2017 15:28 | In again @ 13.83875 ..... cheap as chips ......;0) | tradermichael | |
26/10/2017 15:25 | NY Boy ...Coming up, ex div next Thursday annual yield 7.7% ffs!... The forecast figure is high but nowhere near that high. At 1,391p on the probable 80p div GSK announced, the forecast yield for 2017 and 2018 is about 5.8%. | ![]() anhar | |
26/10/2017 15:19 | If the CEO was a football manager, she'd be gone after this .... | tradermichael | |
26/10/2017 15:08 | BadtimeDo u think it will reach that low? | ![]() action | |
26/10/2017 14:43 | EI....fancy any CNA?Nyboy seems to have gone quiet | ![]() badtime | |
26/10/2017 14:42 | I'll consider a few more at 1350 | ![]() badtime | |
26/10/2017 14:39 | Monty, traded the BT bought this AM at 266.6, 4 pence turn exactly on the buy price, every little helps as Tesco say ) | ![]() essentialinvestor | |
26/10/2017 14:30 | Essential I know one thing if BT figures disappoint in anyway on 2nd Nov, they will get hammered. Going by GSK who increased revenue, lol I think they will end the day 1410p. Total over reaction. | ![]() montyhedge | |
26/10/2017 14:28 | Incredible, bargain of the year, for a tuck away and receive the dividends. Under 1400p wow. | ![]() montyhedge | |
26/10/2017 14:23 | When I posted yesterday at £1510 a share, the market would not like the Q3, did not foresee a share price under 1390!!. | ![]() essentialinvestor | |
26/10/2017 14:12 | We dipped briefly below £13 from memory, might have been early 2016. A good deal of the price "gains" since were on the realisation GSK had a blockbuster Hiv medicine with ViiV. Higher UKX and FX as well helping. | ![]() essentialinvestor |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions